The Dexcom logo is seen on a smartphone screen and in the background.
Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images
Shares of Dexcom tumbled more than 36% in after-hours trading Thursday after the diabetes management company released second-quarter results that missed analysts’ expectations for revenue and offered weak guidance.
This is breaking news. Please refresh for updates.
Source Agencies
